Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:quinoxaline derivative
go back to main search page
Accession:CHEBI:38771 term browser browse the term
Definition:Any naphthyridine derivative that is a derivative of quinoxaline (1,4-naphthyridine).
Synonyms:related_synonym: quinoxaline derivatives;   quinoxalines


show annotations for term's descendants           Sort by:
 
6,7-dimethoxy-2-phenylquinoxaline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] CTD PMID:25896968 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] CTD PMID:25896968 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein] CTD PMID:25896968 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFB mRNA]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased secretion of PDGFB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline results in decreased susceptibility to [PDGFB protein binds to PDGFB protein] CTD PMID:16149045 PMID:23457620 PMID:25896968 NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
JBrowse link
G Pdgfrb platelet derived growth factor receptor beta multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] CTD PMID:16149045 PMID:25896968 NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
JBrowse link
6-Cyano-7-nitroquinoxaline-2,3-dione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aco2 aconitase 2 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Kainic Acid results in decreased activity of ACO2 protein] CTD PMID:11520895 NCBI chr 7:123,102,493...123,145,608
Ensembl chr 7:123,102,468...123,145,635
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA alternative form] CTD PMID:15183516 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Casp3 caspase 3 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]] CTD PMID:24995437 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased expression of FOS] CTD PMID:10401552 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA1 protein CTD PMID:19674091 NCBI chr10:42,441,723...42,760,200
Ensembl chr10:42,614,713...42,760,200
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA2 protein CTD PMID:19674091 NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]
CTD PMID:15385614 PMID:19850060 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]
CTD PMID:15385614 PMID:19850060 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Nefl neurofilament light multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein] CTD PMID:21863293 NCBI chr15:44,799,378...44,803,251
Ensembl chr15:44,799,334...44,804,574
JBrowse link
G Nefm neurofilament medium multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFM protein] CTD PMID:21863293 NCBI chr15:44,855,307...44,860,604
Ensembl chr15:44,855,310...44,860,604
JBrowse link
G Sct secretin multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [SCT protein results in increased secretion of gamma-Aminobutyric Acid] CTD PMID:15963647 NCBI chr 1:214,264,865...214,277,437
Ensembl chr 1:214,264,754...214,265,668
JBrowse link
G Tac1 tachykinin, precursor 1 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [L 703606 results in increased activity of TAC1 protein] CTD PMID:14985054 NCBI chr 4:33,638,853...33,646,819
Ensembl chr 4:33,638,709...33,646,819
JBrowse link
G Vim vimentin multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein] CTD PMID:21863293 NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
JBrowse link
brimonidine tartrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adra2a adrenoceptor alpha 2A multiple interactions ISO
EXP
Brimonidine Tartrate inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein]; Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]; Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]]; Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]] CTD PMID:8397342 PMID:10742289 PMID:12208771 PMID:12598592 NCBI chr 1:274,766,283...274,769,083
Ensembl chr 1:274,766,283...274,769,081
JBrowse link
G Agt angiotensinogen multiple interactions EXP 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] CTD PMID:18250367 NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions ISO Brimonidine Tartrate inhibits the reaction [CFTR protein affects the transport of Chlorides] CTD PMID:12598592 NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases phosphorylation EXP Brimonidine Tartrate results in increased phosphorylation of CREB1 protein CTD PMID:17680988 NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
JBrowse link
G Prkca protein kinase C, alpha affects localization
multiple interactions
EXP Brimonidine Tartrate affects the localization of PRKCA protein
Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein]
CTD PMID:12388232 NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
JBrowse link
G Prkcd protein kinase C, delta affects localization
multiple interactions
EXP Brimonidine Tartrate affects the localization of PRKCD protein
Nitric Oxide deficiency inhibits the reaction [Brimonidine Tartrate affects the localization of PRKCD protein]
CTD PMID:12388232 NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
JBrowse link
G Rhoa ras homolog family member A multiple interactions EXP 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] CTD PMID:18250367 NCBI chr 8:117,082,440...117,116,244
Ensembl chr 8:117,106,576...117,116,167
JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Brimonidine Tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
JBrowse link
cyclazosin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adra1b adrenoceptor alpha 1B multiple interactions EXP cyclazosin binds to and results in decreased activity of ADRA1B protein CTD PMID:15951348 NCBI chr10:29,392,762...29,450,644
Ensembl chr10:29,392,762...29,450,644
JBrowse link
quinalphos term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl hydrocarbon receptor multiple interactions ISO quinalphos binds to and results in increased activity of AHR protein CTD PMID:18835618 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ar androgen receptor multiple interactions ISO Dihydrotestosterone inhibits the reaction [quinalphos results in increased activity of AR protein] CTD PMID:15064155 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Bche butyrylcholinesterase decreases activity
multiple interactions
ISO quinalphos results in decreased activity of BCHE protein
pralidoxime inhibits the reaction [quinalphos results in decreased activity of BCHE protein]
CTD PMID:24052565 NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
JBrowse link
G Cat catalase multiple interactions
decreases activity
ISO Plant Extracts inhibits the reaction [quinalphos results in decreased activity of CAT protein] CTD PMID:24581381 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 decreases expression
multiple interactions
ISO quinalphos results in decreased expression of CYP26B1 mRNA
Plant Extracts inhibits the reaction [quinalphos results in decreased expression of CYP26B1 mRNA]
CTD PMID:24581381 NCBI chr 4:116,261,796...116,278,615
Ensembl chr 4:116,261,796...116,278,615
JBrowse link
G Esr1 estrogen receptor 1 increases activity ISO quinalphos results in increased activity of ESR1 protein CTD PMID:15064155 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Esr2 estrogen receptor 2 increases activity ISO quinalphos results in increased activity of ESR2 protein CTD PMID:15064155 NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions
affects activity
EXP [Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein
quinalphos affects the activity of G6PD protein
CTD PMID:24248738 NCBI chr  X:156,274,800...156,293,935
Ensembl chr  X:156,274,800...156,293,926
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
affects activity
EXP [Monocrotophos co-treated with quinalphos] affects the activity of GSR protein
quinalphos affects the activity of GSR protein
CTD PMID:24248738 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
JBrowse link
G Hsd3b3 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 multiple interactions
decreases expression
ISO Plant Extracts inhibits the reaction [quinalphos results in decreased expression of HSD3B3 mRNA] CTD PMID:24581381 NCBI chr 2:200,756,557...200,762,492
Ensembl chr 2:200,585,748...200,762,492
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO quinalphos binds to and results in increased activity of NR1I2 protein CTD PMID:21115097 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions
decreases expression
ISO Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR mRNA]; Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR protein]
quinalphos results in decreased expression of STAR mRNA; quinalphos results in decreased expression of STAR protein
CTD PMID:24581381 NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
JBrowse link
quinomethionate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Btg2 BTG anti-proliferation factor 2 affects expression ISO quinomethionate affects the expression of BTG2 mRNA CTD PMID:15387888 NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta affects expression ISO quinomethionate affects the expression of CEBPD mRNA CTD PMID:15387888 NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 affects expression ISO quinomethionate affects the expression of CXCL2 mRNA CTD PMID:15387888 NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
JBrowse link
G Etv4 ETS variant transcription factor 4 affects expression ISO quinomethionate affects the expression of ETV4 mRNA CTD PMID:15387888 NCBI chr10:89,685,058...89,700,300
Ensembl chr10:89,685,058...89,700,283
JBrowse link
G Ewsr1 EWS RNA-binding protein 1 affects expression ISO quinomethionate affects the expression of EWSR1 mRNA CTD PMID:15387888 NCBI chr14:85,322,105...85,350,826
Ensembl chr14:85,322,296...85,350,948
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 affects expression ISO quinomethionate affects the expression of FKBP5 mRNA CTD PMID:15387888 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit affects expression ISO quinomethionate affects the expression of FOS mRNA CTD PMID:15387888 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha affects expression ISO quinomethionate affects the expression of GADD45A mRNA CTD PMID:15387888 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
JBrowse link
G Hnrnpf heterogeneous nuclear ribonucleoprotein F affects expression ISO quinomethionate affects the expression of HNRNPF mRNA CTD PMID:15387888 NCBI chr 4:149,957,143...149,978,896
Ensembl chr 4:149,957,206...149,978,895
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit affects expression ISO quinomethionate affects the expression of JUNB mRNA CTD PMID:15387888 NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756
JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit affects expression ISO quinomethionate affects the expression of JUND mRNA CTD PMID:15387888 NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
JBrowse link
G Lmnb1 lamin B1 affects expression ISO quinomethionate affects the expression of LMNB1 mRNA CTD PMID:15387888 NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264
JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 affects expression ISO quinomethionate affects the expression of MAP2K1 mRNA CTD PMID:15387888 NCBI chr 8:69,134,218...69,722,573
Ensembl chr 8:69,134,223...69,164,758
JBrowse link
G Mat2a methionine adenosyltransferase 2A affects expression ISO quinomethionate affects the expression of MAT2A mRNA CTD PMID:15387888 NCBI chr 4:100,297,478...100,303,047
Ensembl chr 4:100,296,075...100,303,080
JBrowse link
G Nfkbia NFKB inhibitor alpha affects expression ISO quinomethionate affects the expression of NFKBIA mRNA CTD PMID:15387888 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
JBrowse link
G Phb prohibitin affects expression ISO quinomethionate affects the expression of PHB mRNA CTD PMID:15387888 NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
JBrowse link
G Ppib peptidylprolyl isomerase B affects expression ISO quinomethionate affects the expression of PPIB mRNA CTD PMID:15387888 NCBI chr 8:71,719,681...71,725,538
Ensembl chr 8:71,719,563...71,725,562
JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase affects expression ISO quinomethionate affects the expression of RAF1 mRNA CTD PMID:15387888 NCBI chr 4:147,532,040...147,592,769
Ensembl chr 4:147,532,042...147,592,699
JBrowse link
G Rarg retinoic acid receptor, gamma affects expression ISO quinomethionate affects the expression of RARG mRNA CTD PMID:15387888 NCBI chr 7:143,840,739...143,863,206
Ensembl chr 7:143,839,980...143,863,186
JBrowse link
G Rbm39 RNA binding motif protein 39 affects expression ISO quinomethionate affects the expression of RBM39 mRNA CTD PMID:15387888 NCBI chr 3:151,691,498...151,724,723
Ensembl chr 3:151,691,514...151,724,654
JBrowse link
G Rnd3 Rho family GTPase 3 affects expression ISO quinomethionate affects the expression of RND3 mRNA CTD PMID:15387888 NCBI chr 3:36,643,374...36,660,727
Ensembl chr 3:36,642,587...36,660,758
JBrowse link
G Sumo1 small ubiquitin-like modifier 1 affects expression ISO quinomethionate affects the expression of SUMO1 mRNA CTD PMID:15387888 NCBI chr 9:66,453,428...66,483,614
Ensembl chr 9:66,453,438...66,483,614
JBrowse link
G Tgfa transforming growth factor alpha affects expression ISO quinomethionate affects the expression of TGFA mRNA CTD PMID:15387888 NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
JBrowse link
G Uqcrc2 ubiquinol cytochrome c reductase core protein 2 affects expression ISO quinomethionate affects the expression of UQCRC2 mRNA CTD PMID:15387888 NCBI chr 1:190,555,177...190,585,741
Ensembl chr 1:190,555,177...190,585,734
JBrowse link
G Vegfa vascular endothelial growth factor A affects expression ISO quinomethionate affects the expression of VEGFA mRNA CTD PMID:15387888 NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
JBrowse link
quizalofop-ethyl term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acox1 acyl-CoA oxidase 1 increases activity
increases expression
multiple interactions
EXP quizalofop-ethyl analog results in increased activity of ACOX1 protein
quizalofop-ethyl analog results in increased expression of ACOX1 mRNA
PPARA protein affects the reaction [quizalofop-ethyl analog results in increased activity of ACOX1 protein]; PPARA protein affects the reaction [quizalofop-ethyl analog results in increased expression of ACOX1 mRNA]
CTD PMID:29626562 NCBI chr10:104,724,534...104,748,003
Ensembl chr10:104,722,958...104,748,050
JBrowse link
G Cat catalase increases activity EXP quizalofop-ethyl analog results in increased activity of CAT protein CTD PMID:29626562 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha increases response to substance
multiple interactions
EXP PPARA protein results in increased susceptibility to quizalofop-ethyl analog
PPARA protein affects the reaction [quizalofop-ethyl analog results in increased activity of ACOX1 protein]; PPARA protein affects the reaction [quizalofop-ethyl analog results in increased expression of ACOX1 mRNA]
CTD PMID:29626562 NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma increases activity ISO quizalofop-ethyl results in increased activity of PPARG protein CTD PMID:31086981 NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
JBrowse link
XL147 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of A2M mRNA CTD PMID:27935865 NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
JBrowse link
G Abca8 ATP binding cassette subfamily A member 8 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ABCA8B mRNA CTD PMID:27935865 NCBI chr10:98,236,919...98,308,288
Ensembl chr10:98,237,141...98,294,522
JBrowse link
G Abhd14b abhydrolase domain containing 14b multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ABHD14B mRNA] CTD PMID:29891994 NCBI chr 8:115,149,638...115,154,556
Ensembl chr 8:115,150,514...115,154,550
JBrowse link
G Acod1 aconitate decarboxylase 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ACOD1 mRNA CTD PMID:27935865 NCBI chr15:93,612,968...93,622,322
Ensembl chr15:93,612,971...93,622,358
JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ACTA2 mRNA] CTD PMID:29891994 NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
JBrowse link
G Actg2 actin gamma 2, smooth muscle multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ACTG2 mRNA CTD PMID:27935865 NCBI chr 4:115,215,160...115,239,746
Ensembl chr 4:115,215,060...115,239,723
JBrowse link
G Adam8 ADAM metallopeptidase domain 8 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADAM8 mRNA CTD PMID:27935865 NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349
JBrowse link
G Adcy5 adenylate cyclase 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCY5 mRNA CTD PMID:27935865 NCBI chr11:68,695,839...68,842,452
Ensembl chr11:68,695,839...68,842,320
JBrowse link
G Adcyap1r1 ADCYAP receptor type I multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCYAP1R1 mRNA CTD PMID:27935865 NCBI chr 4:85,662,809...85,711,696
Ensembl chr 4:85,662,892...85,711,696
JBrowse link
G Adgra2 adhesion G protein-coupled receptor A2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADGRA2 mRNA CTD PMID:27935865 NCBI chr16:69,094,587...69,133,015
Ensembl chr16:69,095,936...69,132,584
JBrowse link
G Adgrg3 adhesion G protein-coupled receptor G3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADGRG3 mRNA CTD PMID:27935865 NCBI chr19:10,392,001...10,422,606
Ensembl chr19:10,392,004...10,421,010
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADIPOQ mRNA CTD PMID:27935865 NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
JBrowse link
G Adora1 adenosine A1 receptor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADORA1 mRNA CTD PMID:27935865 NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
JBrowse link
G Agbl1 ATP/GTP binding protein-like 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGBL1 mRNA CTD PMID:27935865 NCBI chr 1:137,798,862...138,711,126
Ensembl chr 1:137,799,185...138,711,126
JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGTR2 mRNA CTD PMID:27935865 NCBI chr  X:119,389,480...119,393,845
Ensembl chr  X:119,390,013...119,393,842
JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AKR1D1 mRNA CTD PMID:27935865 NCBI chr 4:65,110,706...65,143,930
Ensembl chr 4:65,110,746...65,143,941
JBrowse link
G Ambp alpha-1-microglobulin/bikunin precursor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AMBP mRNA CTD PMID:27935865 NCBI chr 5:78,975,690...78,986,021
Ensembl chr 5:78,975,678...78,985,990
JBrowse link
G Anos1 anosmin 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of WFDC17 mRNA CTD PMID:27935865 Ensembl chr10:70,999,780...71,000,627 JBrowse link
G Aoc3 amine oxidase, copper containing 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AOC3 mRNA CTD PMID:27935865 NCBI chr10:89,251,370...89,259,313
Ensembl chr10:89,251,370...89,259,313
JBrowse link
G Apoc2 apolipoprotein C2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of APOC2 mRNA CTD PMID:27935865 NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136
JBrowse link
G Apol9a apolipoprotein L 9a multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of APOL6 mRNA CTD PMID:27935865 NCBI chr 7:118,927,013...118,933,778
Ensembl chr 7:118,927,008...118,933,812
JBrowse link
G Arhgap36 Rho GTPase activating protein 36 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ARHGAP36 mRNA CTD PMID:27935865 NCBI chr  X:136,460,227...136,495,646
Ensembl chr  X:136,460,215...136,495,646
JBrowse link
G Arhgef19 Rho guanine nucleotide exchange factor 19 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARHGEF19 mRNA] CTD PMID:29891994 NCBI chr 5:159,754,954...159,773,699
Ensembl chr 5:159,755,535...159,773,699
JBrowse link
G Armcx6 armadillo repeat containing, X-linked 6 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARMCX6 mRNA] CTD PMID:29891994 NCBI chr  X:105,565,733...105,573,387
Ensembl chr  X:105,565,747...105,568,343
JBrowse link
G Asb10 ankyrin repeat and SOCS box-containing 10 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB10 mRNA CTD PMID:27935865 NCBI chr 4:7,158,293...7,167,505
Ensembl chr 4:7,158,448...7,167,509
JBrowse link
G Asb13 ankyrin repeat and SOCS box-containing 13 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASB13 mRNA] CTD PMID:29891994 NCBI chr17:70,215,401...70,234,103
Ensembl chr17:70,215,401...70,234,103
JBrowse link
G Asb16 ankyrin repeat and SOCS box-containing 16 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB16 mRNA CTD PMID:27935865 NCBI chr10:90,217,979...90,224,984
Ensembl chr10:90,217,924...90,226,537
JBrowse link
G Ascl2 achaete-scute family bHLH transcription factor 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASCL2 mRNA] CTD PMID:29891994 NCBI chr 1:216,154,002...216,156,409
Ensembl chr 1:216,154,002...216,156,409
JBrowse link
G Atp1a2 ATPase Na+/K+ transporting subunit alpha 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ATP1A2 mRNA CTD PMID:27935865 NCBI chr13:90,651,682...90,676,629
Ensembl chr13:90,651,686...90,676,629
JBrowse link
G Atp1a3 ATPase Na+/K+ transporting subunit alpha 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ATP1A3 mRNA CTD PMID:27935865 NCBI chr 1:81,852,423...81,881,565
Ensembl chr 1:81,852,429...81,881,549
JBrowse link
G Avpr1a arginine vasopressin receptor 1A multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AVPR1A mRNA CTD PMID:27935865 NCBI chr 7:67,341,366...67,345,290
Ensembl chr 7:67,341,080...67,345,308
JBrowse link
G B4galnt2 beta-1,4-N-acetyl-galactosaminyl transferase 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of B4GALNT2 mRNA CTD PMID:27935865 NCBI chr10:83,677,768...83,701,487 JBrowse link
G Bend4 BEN domain containing 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BEND4 mRNA CTD PMID:27935865 NCBI chr14:42,399,359...42,401,643
NCBI chr14:42,401,665...42,437,957
Ensembl chr14:42,401,706...42,431,480
JBrowse link
G Bhlha15 basic helix-loop-helix family, member a15 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BHLHA15 mRNA CTD PMID:27935865 NCBI chr12:12,403,385...12,409,103
Ensembl chr12:12,403,385...12,407,561
JBrowse link
G Bpifa5 BPI fold containing family A, member 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BPIFA5 mRNA CTD PMID:27935865 NCBI chr 3:149,643,481...149,649,398
Ensembl chr 3:149,643,481...149,649,398
JBrowse link
G Bpifb1 BPI fold containing family B, member 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BPIFB1 mRNA CTD PMID:27935865 NCBI chr 3:149,668,099...149,702,399
Ensembl chr 3:149,668,102...149,702,399
JBrowse link
G Bricd5 BRICHOS domain containing 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BRICD5 mRNA CTD PMID:27935865 NCBI chr10:13,839,599...13,841,132
Ensembl chr10:13,839,956...13,841,018
JBrowse link
G Btn1a1 butyrophilin, subfamily 1, member A1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BTN1A1 mRNA CTD PMID:27935865 NCBI chr17:43,899,155...43,909,042
Ensembl chr17:43,900,450...43,909,627
JBrowse link
G C1qtnf2 C1q and TNF related 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF2 mRNA CTD PMID:27935865 NCBI chr10:29,067,102...29,084,035
Ensembl chr10:29,067,102...29,084,035
JBrowse link
G C1qtnf7 C1q and TNF related 7 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF7 mRNA CTD PMID:27935865 NCBI chr14:72,011,518...72,122,257
Ensembl chr14:72,011,461...72,122,158
JBrowse link
G C5ar1 complement C5a receptor 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR1 mRNA CTD PMID:27935865 NCBI chr 1:78,186,777...78,195,132
Ensembl chr 1:78,186,776...78,195,328
JBrowse link
G C5ar2 complement component 5a receptor 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR2 mRNA CTD PMID:27935865 NCBI chr 1:78,165,155...78,183,426
Ensembl chr 1:78,166,810...78,180,216
JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CAR3 mRNA CTD PMID:27935865 NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CAMK2N1 mRNA] CTD PMID:29891994 NCBI chr 5:156,876,706...156,878,486
Ensembl chr 5:156,876,706...156,878,486
JBrowse link
G Card10 caspase recruitment domain family, member 10 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CARD10 mRNA] CTD PMID:29891994 NCBI chr 7:119,998,639...120,028,632
Ensembl chr 7:119,999,472...120,027,026
JBrowse link
G Cbx4 chromobox 4 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CBX4 mRNA] CTD PMID:29891994 NCBI chr10:108,190,947...108,196,455
Ensembl chr10:108,190,995...108,196,217
JBrowse link
G Ccdc42 coiled-coil domain containing 42 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCDC42 mRNA CTD PMID:27935865 NCBI chr10:55,169,312...55,179,489
Ensembl chr10:55,169,282...55,181,416
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL2 mRNA CTD PMID:27935865 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL3 mRNA CTD PMID:27935865 NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL7 mRNA CTD PMID:27935865 NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
JBrowse link
G Ccna1 cyclin A1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNA1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CCNA1 mRNA] CTD PMID:27935865 PMID:29891994 NCBI chr 2:144,456,689...144,503,570
Ensembl chr 2:144,458,153...144,467,912
JBrowse link
G Ccno cyclin O multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNO mRNA CTD PMID:27935865 NCBI chr 2:44,857,043...44,860,317
Ensembl chr 2:44,857,213...44,860,315
JBrowse link
G Cd177 CD177 molecule multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD177 mRNA CTD PMID:27935865 NCBI chr 1:82,964,683...82,987,306
Ensembl chr 1:82,964,683...82,987,253
JBrowse link
G Cd5l Cd5 molecule-like multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD5L mRNA CTD PMID:27935865 NCBI chr 2:186,685,104...186,696,117
Ensembl chr 2:186,685,104...186,696,117
JBrowse link
G Cdc20b cell division cycle 20B multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CDC20B mRNA CTD PMID:27935865 NCBI chr 2:44,916,806...44,947,860 JBrowse link
G Cdh26 cadherin 26 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDH26 mRNA CTD PMID:27935865 NCBI chr 3:173,969,004...174,020,867
Ensembl chr 3:173,969,273...174,019,766
JBrowse link
G Cdhr1 cadherin-related family member 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDHR1 mRNA CTD PMID:27935865 NCBI chr16:14,328,161...14,348,049
Ensembl chr16:14,328,160...14,348,046
JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CELSR3 mRNA CTD PMID:27935865 NCBI chr 8:117,620,293...117,648,034
Ensembl chr 8:117,620,317...117,648,028
JBrowse link
G Cfd complement factor D multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CFD mRNA CTD PMID:27935865 NCBI chr 7:12,634,216...12,635,939
Ensembl chr 7:12,634,216...12,635,943
JBrowse link
G Chi3l1 chitinase 3 like 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHIL1 mRNA CTD PMID:27935865 NCBI chr13:51,022,844...51,030,797
Ensembl chr13:51,022,681...51,030,802
JBrowse link
G Chodl chondrolectin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHODL mRNA CTD PMID:27935865 NCBI chr11:17,537,980...17,560,305
Ensembl chr11:17,538,063...17,560,296
JBrowse link
G Chrdl1 chordin-like 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRDL1 mRNA CTD PMID:27935865 NCBI chr  X:114,554,359...114,658,975
Ensembl chr  X:114,554,359...114,658,931
JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRM2 mRNA CTD PMID:27935865 NCBI chr 4:64,089,028...64,091,090
Ensembl chr 4:64,088,900...64,091,090
JBrowse link
G Chst5 carbohydrate sulfotransferase 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHST5 mRNA CTD PMID:27935865 NCBI chr19:44,115,065...44,136,092
Ensembl chr19:44,115,120...44,135,387
JBrowse link
G Cidec cell death-inducing DFFA-like effector c multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CIDEC mRNA CTD PMID:27935865 NCBI chr 4:145,377,482...145,390,497
Ensembl chr 4:145,377,431...145,390,497
JBrowse link
G Ckmt2 creatine kinase, mitochondrial 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CKMT2 mRNA CTD PMID:27935865 NCBI chr 2:21,422,680...21,452,797
Ensembl chr 2:21,422,818...21,437,193
JBrowse link
G Clec4d C-type lectin domain family 4, member D multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4D mRNA CTD PMID:27935865 NCBI chr 4:156,253,084...156,264,766
Ensembl chr 4:156,253,079...156,264,769
JBrowse link
G Clec4e C-type lectin domain family 4, member E multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4E mRNA CTD PMID:27935865 NCBI chr 4:156,271,087...156,276,243
Ensembl chr 4:156,270,920...156,276,304
JBrowse link
G Cnn1 calponin 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNN1 mRNA CTD PMID:27935865 NCBI chr 8:23,113,083...23,121,748
Ensembl chr 8:23,113,048...23,121,761
JBrowse link
G Cntfr ciliary neurotrophic factor receptor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNTFR mRNA CTD PMID:27935865 NCBI chr 5:58,041,114...58,078,687
Ensembl chr 5:58,041,146...58,078,545
JBrowse link
G Colq collagen like tail subunit of asymmetric acetylcholinesterase multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COLQ mRNA CTD PMID:27935865 NCBI chr16:7,626,380...7,681,621
Ensembl chr16:7,627,603...7,681,576
JBrowse link
G Cox7a1 cytochrome c oxidase subunit 7A1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COX7A1 mRNA CTD PMID:27935865 NCBI chr 1:88,619,619...88,650,672
Ensembl chr 1:91,071,493...91,074,294
Ensembl chr 1:91,071,493...91,074,294
JBrowse link
G Cplx1 complexin 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CPLX1 mRNA CTD PMID:27935865 NCBI chr14:2,194,895...2,226,610
Ensembl chr14:2,194,933...2,226,598
JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CREB1 mRNA] CTD PMID:29891994 NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CREB3L3 mRNA CTD PMID:27935865 NCBI chr 7:11,490,852...11,499,287
Ensembl chr 7:11,490,852...11,499,282
JBrowse link
G Crisp3 cysteine-rich secretory protein 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISP3 mRNA CTD PMID:27935865 NCBI chr 9:24,047,405...24,088,066
Ensembl chr 9:24,066,303...24,088,064
JBrowse link
G Crispld1 cysteine-rich secretory protein LCCL domain containing 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISPLD1 mRNA CTD PMID:27935865 NCBI chr 5:663,750...711,033
Ensembl chr 5:670,754...711,033
JBrowse link
G Cryl1 crystallin, lambda 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CRYL1 mRNA] CTD PMID:29891994 NCBI chr15:37,543,727...37,663,586
Ensembl chr15:37,543,727...37,663,584
JBrowse link
G Csf3 colony stimulating factor 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3 mRNA CTD PMID:27935865 NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
JBrowse link
G Csf3r colony stimulating factor 3 receptor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3R mRNA CTD PMID:27935865 NCBI chr 5:144,031,353...144,051,966
Ensembl chr 5:144,031,402...144,051,600
JBrowse link
G Csrp1 cysteine and glycine-rich protein 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CSRP1 mRNA] CTD PMID:29891994 NCBI chr13:52,553,843...52,575,054
Ensembl chr13:52,553,775...52,575,051
JBrowse link
G Ctsc cathepsin C multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CTSC mRNA] CTD PMID:29891994 NCBI chr 1:151,918,514...151,949,979
Ensembl chr 1:151,918,571...151,949,983
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CXCL12 mRNA CTD PMID:27935865 NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL2 mRNA CTD PMID:27935865 NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL3 mRNA CTD PMID:27935865 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL5 mRNA CTD PMID:27935865 NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407
JBrowse link
G Cxcr2 C-X-C motif chemokine receptor 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCR2 mRNA CTD PMID:27935865 NCBI chr 9:81,427,275...81,435,065
Ensembl chr 9:81,427,730...81,434,102
JBrowse link
G Cxx1a CAAX box 1A multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RTL8A mRNA] CTD PMID:29891994 NCBI chr11:86,649,632...86,655,243 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYP2E1 mRNA CTD PMID:27935865 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp4f18 cytochrome P450, family 4, subfamily f, polypeptide 18 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CYP4F18 mRNA CTD PMID:27935865 NCBI chr16:19,501,680...19,528,935
Ensembl chr16:19,410,810...19,528,999
JBrowse link
G Cys1 cystin 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYS1 mRNA CTD PMID:27935865 NCBI chr 6:43,844,937...43,862,131
Ensembl chr 6:43,844,937...43,862,131
JBrowse link
G Dcaf12l1 DDB1 and CUL4 associated factor 12-like 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCAF12L1 mRNA CTD PMID:27935865 NCBI chr  X:131,340,045...131,344,038
Ensembl chr  X:131,340,045...131,343,853
JBrowse link
G Dchs1 dachsous cadherin-related 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCHS1 mRNA CTD PMID:27935865 NCBI chr 1:170,594,981...170,629,062
Ensembl chr 1:170,594,822...170,628,915
JBrowse link
G Degs2 delta(4)-desaturase, sphingolipid 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of DEGS2 mRNA CTD PMID:27935865 NCBI chr 6:132,591,968...132,608,600
Ensembl chr 6:132,591,969...132,608,600
JBrowse link
G Derl3 derlin 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DERL3 mRNA CTD PMID:27935865 NCBI chr20:13,692,102...13,707,645
Ensembl chr20:13,704,314...13,706,205
JBrowse link
G Dhdh dihydrodiol dehydrogenase multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DHDH mRNA] CTD PMID:29891994 NCBI chr 1:101,465,937...101,476,867
Ensembl chr 1:101,466,677...101,476,867
JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMBT1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DMBT1 mRNA] CTD PMID:27935865 PMID:29891994 NCBI chr 1:201,620,642...201,689,905
NCBI chr 1:203,149,414...203,228,705
JBrowse link
G Dmrta1 DMRT-like family A1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMRTA1 mRNA CTD PMID:27935865 NCBI chr 5:108,278,217...108,284,757
Ensembl chr 5:108,278,217...108,284,757
JBrowse link
G Dpt dermatopontin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DPT mRNA CTD PMID:27935865 NCBI chr13:83,073,307...83,102,404
Ensembl chr13:83,073,544...83,102,401
JBrowse link
G Drd1 dopamine receptor D1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DRD1 mRNA CTD PMID:27935865 NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
JBrowse link
G Edn3 endothelin 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EDN3 mRNA CTD PMID:27935865 NCBI chr 3:172,856,730...172,879,276
Ensembl chr 3:172,856,733...172,880,450
JBrowse link
G Eef1a2 eukaryotic translation elongation factor 1 alpha 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of EEF1A2 mRNA] CTD PMID:29891994 NCBI chr 3:176,657,104...176,666,282
Ensembl chr 3:176,657,107...176,666,282
JBrowse link
G Egf epidermal growth factor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EGF mRNA CTD PMID:27935865 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Epha3 Eph receptor A3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA3 mRNA CTD PMID:27935865 NCBI chr11:421,253...783,037
Ensembl chr11:421,135...782,954
JBrowse link
G Epha5 EPH receptor A5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA5 mRNA CTD PMID:27935865 NCBI chr14:25,589,312...25,958,258
Ensembl chr14:25,589,762...25,958,227
JBrowse link
G Epyc epiphycan multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPYC mRNA CTD PMID:27935865 NCBI chr 7:38,897,278...38,934,989
Ensembl chr 7:38,897,278...38,934,985
JBrowse link
G F2rl1 F2R like trypsin receptor 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F2RL1 mRNA] CTD PMID:29891994 NCBI chr 2:25,222,324...25,235,275
Ensembl chr 2:25,222,328...25,235,275
JBrowse link
G F2rl3 F2R like thrombin or trypsin receptor 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of F2RL3 mRNA CTD PMID:27935865 NCBI chr16:18,817,797...18,819,790
Ensembl chr16:18,814,622...18,819,833
JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F3 mRNA] CTD PMID:29891994 NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
JBrowse link
G Fam13c family with sequence similarity 13, member C multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FAM13C mRNA CTD PMID:27935865 NCBI chr20:19,358,869...19,470,212
Ensembl chr20:19,360,230...19,479,325
JBrowse link
G Fat2 FAT atypical cadherin 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FAT2 mRNA] CTD PMID:29891994 NCBI chr10:40,583,025...40,682,598
Ensembl chr10:40,584,403...40,657,861
JBrowse link
G Fbln7 fibulin 7 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBLN7 mRNA CTD PMID:27935865 NCBI chr 3:121,407,981...121,441,660
Ensembl chr 3:121,408,146...121,440,787
JBrowse link
G Fbxo40 F-box protein 40 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBXO40 mRNA CTD PMID:27935865 NCBI chr11:66,713,913...66,731,195
Ensembl chr11:66,713,888...66,731,198
JBrowse link
G Fcrl2 Fc receptor-like 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FCRLS mRNA CTD PMID:27935865 NCBI chr 2:186,594,442...186,605,115
Ensembl chr 2:186,595,051...186,606,172
JBrowse link
G Fhod3 formin homology 2 domain containing 3 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FHOD3 mRNA] CTD PMID:29891994 NCBI chr18:16,650,786...17,332,209
Ensembl chr18:16,650,806...17,332,210
JBrowse link
G Foxn4 forkhead box N4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FOXN4 mRNA CTD PMID:27935865 NCBI chr12:48,101,012...48,121,281
Ensembl chr12:48,101,673...48,121,270
JBrowse link
G Fpr2 formyl peptide receptor 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of FPR2 mRNA CTD PMID:27935865 NCBI chr 1:59,800,558...59,809,507
Ensembl chr 1:59,800,984...59,802,401
JBrowse link
G Frem1 Fras1 related extracellular matrix 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FREM1 mRNA CTD PMID:27935865 NCBI chr 5:101,018,009...101,166,794
Ensembl chr 5:101,020,448...101,166,651
JBrowse link
G Frmpd4 FERM and PDZ domain containing 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRMPD4 mRNA CTD PMID:27935865 NCBI chr  X:27,231,648...28,206,890
Ensembl chr  X:28,072,826...28,204,260
JBrowse link
G Frzb frizzled-related protein multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRZB mRNA CTD PMID:27935865 NCBI chr 3:67,635,604...67,668,772
Ensembl chr 3:67,635,607...67,668,772
JBrowse link
G Gabra4 gamma-aminobutyric acid type A receptor subunit alpha 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GABRA4 mRNA CTD PMID:27935865 NCBI chr14:39,154,072...39,230,994
Ensembl chr14:39,154,529...39,231,695
JBrowse link
G Gal3st2 galactose-3-O-sulfotransferase 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GAL3ST2 mRNA CTD PMID:27935865 NCBI chr 9:100,982,996...100,994,226
Ensembl chr 9:100,990,523...100,993,206
JBrowse link
G Gask1a golgi associated kinase 1A multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GASK1A mRNA CTD PMID:27935865 NCBI chr 8:130,581,072...130,614,118
Ensembl chr 8:130,581,062...130,612,510
JBrowse link
G Gcnt4 glucosaminyl (N-acetyl) transferase 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GCNT4 mRNA CTD PMID:27935865 Ensembl chr 2:27,713,880...27,780,119 JBrowse link
G Gdf10 growth differentiation factor 10 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GDF10 mRNA CTD PMID:27935865 NCBI chr16:10,250,508...10,262,383
Ensembl chr16:10,250,404...10,263,150
JBrowse link
G Gfra3 GDNF family receptor alpha 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GFRA3 mRNA CTD PMID:27935865 NCBI chr18:27,491,860...27,520,133
Ensembl chr18:27,491,845...27,520,295
JBrowse link
G Gja3 gap junction protein, alpha 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GJA3 mRNA CTD PMID:27935865 NCBI chr15:37,298,607...37,325,370
Ensembl chr15:37,299,738...37,325,178
JBrowse link
G Gprasp2 G protein-coupled receptor associated sorting protein 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GPRASP2 mRNA CTD PMID:27935865 NCBI chr  X:106,357,240...106,363,455
Ensembl chr  X:106,360,393...106,363,300
JBrowse link
G Gstk1 glutathione S-transferase kappa 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTK1 mRNA] CTD PMID:29891994 NCBI chr 4:71,621,777...71,626,096
Ensembl chr 4:71,621,729...71,626,107
JBrowse link
G Gstz1 glutathione S-transferase zeta 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTZ1 mRNA] CTD PMID:29891994 NCBI chr 6:111,176,798...111,187,246
Ensembl chr 6:111,176,798...111,187,244
JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HES1 mRNA] CTD PMID:29891994 NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248
JBrowse link
G Hhip Hedgehog-interacting protein multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of HHIP mRNA CTD PMID:27935865 NCBI chr19:31,525,134...31,614,487
Ensembl chr19:31,524,671...31,614,246
JBrowse link
G Hsd17b8 hydroxysteroid (17-beta) dehydrogenase 8 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HSD17B8 mRNA] CTD PMID:29891994 NCBI chr20:3,817,212...3,819,316
Ensembl chr20:3,817,179...3,819,235
JBrowse link
G Htr2b 5-hydroxytryptamine receptor 2B multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of HTR2B mRNA CTD PMID:27935865 NCBI chr 9:93,112,781...93,130,135
Ensembl chr 9:93,112,805...93,125,014
JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IDH2 mRNA] CTD PMID:29891994 NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of IDO1 mRNA CTD PMID:27935865 NCBI chr16:72,216,326...72,228,098
Ensembl chr16:72,216,326...72,228,098
JBrowse link
G Ifi27l2b interferon, alpha-inducible protein 27 like 2B multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IFI27L2 mRNA] CTD PMID:29891994 NCBI chr 6:127,336,305...127,337,791
Ensembl chr 6:127,336,305...127,337,791
JBrowse link
G Igll1 immunoglobulin lambda-like polypeptide 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IGLL1 mRNA CTD PMID:27935865 NCBI chr11:88,388,378...88,391,524
Ensembl chr11:88,388,378...88,391,370
JBrowse link
G Il19 interleukin 19 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL19 mRNA CTD PMID:27935865 NCBI chr13:47,663,592...47,677,869
Ensembl chr13:47,664,080...47,670,407
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL1B mRNA CTD PMID:27935865 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
JBrowse link
G Inmt indolethylamine N-methyltransferase multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of INMT mRNA CTD PMID:27935865 NCBI chr 4:85,381,907...85,386,203
Ensembl chr 4:85,381,889...85,386,231
JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRF7 mRNA] CTD PMID:29891994 NCBI chr 1:214,249,388...214,252,909
Ensembl chr 1:214,248,837...214,252,456
JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRS2 mRNA] CTD PMID:29891994 NCBI chr16:83,824,515...83,848,569
Ensembl chr16:83,824,430...83,848,684
JBrowse link
G Isg15 ISG15 ubiquitin-like modifier multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ISG15 mRNA] CTD PMID:29891994 NCBI chr 5:173,624,862...173,629,124
Ensembl chr 5:173,624,310...173,626,248
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR1 mRNA] CTD PMID:29891994 NCBI chr 4:140,247,297...140,580,749
Ensembl chr 4:140,247,313...140,580,748
JBrowse link
G Itpr3 inositol 1,4,5-trisphosphate receptor, type 3 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR3 mRNA] CTD PMID:29891994 NCBI chr20:5,645,894...5,711,702
Ensembl chr20:5,646,097...5,711,702
JBrowse link
G Jchain joining chain of multimeric IgA and IgM multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of JCHAIN mRNA CTD PMID:27935865 NCBI chr14:21,176,841...21,183,731
Ensembl chr14:21,177,237...21,183,542
JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KANK4 mRNA CTD PMID:27935865 NCBI chr 5:117,376,425...117,440,643
Ensembl chr 5:117,376,423...117,440,254
JBrowse link
G Kbtbd12 kelch repeat and BTB domain containing 12 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KBTBD12 mRNA CTD PMID:27935865 NCBI chr 4:120,492,541...120,567,755
Ensembl chr 4:120,551,599...120,559,078
JBrowse link
G Kcna1 potassium voltage-gated channel subfamily A member 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNA1 mRNA CTD PMID:27935865 NCBI chr 4:159,190,781...159,192,526
Ensembl chr 4:159,190,804...159,192,526
JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNMA1 mRNA CTD PMID:27935865 NCBI chr15:344,204...1,048,849
Ensembl chr15:344,360...1,047,956
JBrowse link
G Klhl13 kelch-like family member 13 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL13 mRNA CTD PMID:27935865 NCBI chr  X:121,578,965...121,735,014
Ensembl chr  X:121,578,940...121,731,543
JBrowse link
G Klhl33 kelch-like family member 33 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL33 mRNA CTD PMID:27935865 NCBI chr15:27,811,226...27,819,808
Ensembl chr15:27,813,393...27,815,261
JBrowse link
G Klhl4 kelch-like family member 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL4 mRNA CTD PMID:27935865 NCBI chr  X:86,125,929...86,229,565
Ensembl chr  X:86,126,157...86,229,563
JBrowse link
G Klk6 kallikrein related-peptidase 6 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KLK6 mRNA CTD PMID:27935865 NCBI chr 1:99,762,195...99,769,486
Ensembl chr 1:99,762,253...99,769,488
JBrowse link
G Kng2 kininogen 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KNG2 mRNA CTD PMID:27935865 NCBI chr11:81,509,185...81,516,759 JBrowse link
G Krt16 keratin 16 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT16 mRNA CTD PMID:27935865 NCBI chr10:88,149,210...88,152,167
Ensembl chr10:88,149,345...88,152,064
JBrowse link
G Krt84 keratin 84 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT84 mRNA CTD PMID:27935865 NCBI chr 7:143,180,212...143,187,684
Ensembl chr 7:143,179,835...143,187,648
JBrowse link
G Letmd1 LETM1 domain containing 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LETMD1 mRNA] CTD PMID:29891994 NCBI chr 7:142,106,364...142,119,900
Ensembl chr 7:142,106,465...142,119,899
JBrowse link
G Lin28a lin-28 homolog A multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIN28A mRNA CTD PMID:27935865 NCBI chr 5:152,230,343...152,247,873
Ensembl chr 5:152,230,343...152,247,332
JBrowse link
G Lipf lipase F, gastric type multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LIPF mRNA CTD PMID:27935865 NCBI chr 1:252,284,464...252,302,811
Ensembl chr 1:252,284,464...252,302,811
JBrowse link
G Lipn lipase, family member N multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIPN mRNA CTD PMID:27935865 NCBI chr 1:252,375,941...252,394,226
Ensembl chr 1:252,375,933...252,396,460
JBrowse link
G Lman1l lectin, mannose-binding, 1 like multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMAN1L mRNA CTD PMID:27935865 NCBI chr 8:62,386,806...62,400,370
Ensembl chr 8:62,386,806...62,399,648
JBrowse link
G Lmo4 LIM domain only 4 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LMO4 mRNA] CTD PMID:29891994 NCBI chr 2:250,218,635...250,235,435
Ensembl chr 2:250,218,641...250,241,673
JBrowse link
G Lmod3 leiomodin 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMOD3 mRNA CTD PMID:27935865 NCBI chr 4:129,604,378...129,619,136
Ensembl chr 4:129,604,267...129,619,142
JBrowse link
G LOC100912509 intermediate filament tail domain-containing protein 1-like multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LMNTD1 mRNA CTD PMID:27935865 NCBI chr 4:180,141,742...180,153,948
Ensembl chr 4:180,141,986...180,153,906
JBrowse link
G LOC102550598 small proline-rich protein 2I-like multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2G mRNA CTD PMID:27935865 NCBI chr 2:192,520,019...192,521,188
Ensembl chr 2:192,520,733...192,520,960
JBrowse link
G LOC690948 similar to paired-Ig-like receptor A11 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LILRA6 mRNA CTD PMID:27935865 NCBI chr 1:63,963,855...63,971,869
Ensembl chr 1:63,964,155...63,967,366
JBrowse link
G Lrg1 leucine-rich alpha-2-glycoprotein 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LRG1 mRNA CTD PMID:27935865 NCBI chr 9:10,952,424...10,954,664
Ensembl chr 9:10,952,374...10,954,681
JBrowse link
G Lrrc3b leucine rich repeat containing 3B multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC3B mRNA CTD PMID:27935865 NCBI chr15:11,221,161...11,299,563
Ensembl chr15:11,298,478...11,299,257
JBrowse link
G Lrrc4b leucine rich repeat containing 4B multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC4B mRNA CTD PMID:27935865 NCBI chr 1:100,434,418...100,468,914
Ensembl chr 1:100,447,998...100,468,868
JBrowse link
G Mamstr MEF2 activating motif and SAP domain containing transcriptional regulator multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MAMSTR mRNA CTD PMID:27935865 NCBI chr 1:101,621,733...101,628,379
Ensembl chr 1:101,623,308...101,627,609
JBrowse link
G Map1lc3a microtubule-associated protein 1 light chain 3 alpha multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of MAP1LC3A mRNA] CTD PMID:29891994 NCBI chr 3:150,801,289...150,802,935
Ensembl chr 3:150,801,289...150,802,935
JBrowse link
G Mcidas multiciliate differentiation and DNA synthesis associated cell cycle protein multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MCIDAS mRNA CTD PMID:27935865 NCBI chr 2:44,863,246...44,869,732
Ensembl chr 2:44,863,252...44,870,536
JBrowse link
G Mfap4 microfibril associated protein 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MFAP4 mRNA CTD PMID:27935865 NCBI chr10:47,765,463...47,768,484
Ensembl chr10:47,765,432...47,768,483
JBrowse link
G Mgam maltase-glucoamylase multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MGAM mRNA CTD PMID:27935865 NCBI chr 4:69,018,592...69,114,027
Ensembl chr 4:68,849,033...68,996,961
JBrowse link
G Mme membrane metallo-endopeptidase multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MME mRNA CTD PMID:27935865 NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738
JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP10 mRNA CTD PMID:27935865 NCBI chr 8:5,734,348...5,742,243
Ensembl chr 8:5,734,348...5,742,243
JBrowse link
G Mmp8 matrix metallopeptidase 8 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP8 mRNA CTD PMID:27935865 NCBI chr 8:5,768,808...5,777,741
Ensembl chr 8:5,768,811...5,778,702
JBrowse link
G Mstn myostatin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MSTN mRNA CTD PMID:27935865 NCBI chr 9:53,310,977...53,315,804
Ensembl chr 9:53,309,598...53,315,915
JBrowse link
G Msx3 msh homeobox 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MSX3 mRNA CTD PMID:27935865 NCBI chr 1:212,514,223...212,517,151
Ensembl chr 1:212,514,223...212,517,151
JBrowse link
G Musk muscle associated receptor tyrosine kinase multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MUSK mRNA CTD PMID:27935865 NCBI chr 5:75,392,790...75,498,694
Ensembl chr 5:75,392,790...75,498,694
JBrowse link
G Myadml2 myeloid-associated differentiation marker-like 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYADML2 mRNA CTD PMID:27935865 NCBI chr10:109,822,170...109,827,328
Ensembl chr10:109,825,515...109,827,143
JBrowse link
G Myh13 myosin heavy chain 13 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYH13 mRNA CTD PMID:27935865 NCBI chr10:53,921,077...53,927,553 JBrowse link
G Myoc myocilin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOC mRNA CTD PMID:27935865 NCBI chr13:80,517,531...80,527,928
Ensembl chr13:80,517,536...80,527,928
JBrowse link
G Myocd myocardin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOCD mRNA CTD PMID:27935865 NCBI chr10:51,682,053...51,781,458
Ensembl chr10:51,683,540...51,778,986
JBrowse link
G Myog myogenin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOG mRNA CTD PMID:27935865 NCBI chr13:51,126,459...51,129,048
Ensembl chr13:51,126,459...51,129,048
JBrowse link
G Myoz3 myozenin 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOZ3 mRNA CTD PMID:27935865 NCBI chr18:55,840,535...55,861,217
Ensembl chr18:55,843,164...55,859,333
JBrowse link
G Nags N-acetylglutamate synthase multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NAGS mRNA CTD PMID:27935865 NCBI chr10:90,084,607...90,089,693
Ensembl chr10:90,085,559...90,089,693
JBrowse link
G Nell2 neural EGFL like 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NELL2 mRNA CTD PMID:27935865 NCBI chr 7:136,526,497...136,853,820
Ensembl chr 7:136,526,496...136,853,957
JBrowse link
G Nfe2 nuclear factor, erythroid 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NFE2 mRNA CTD PMID:27935865 NCBI chr 7:144,872,739...144,880,092
Ensembl chr 7:144,872,747...144,880,092
JBrowse link
G Nkx2-8 NK2 homeobox 8 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NKX2-9 mRNA CTD PMID:27935865 NCBI chr 6:77,506,882...77,508,585
Ensembl chr 6:77,506,882...77,508,585
JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NKX3-1 mRNA CTD PMID:27935865 NCBI chr15:51,065,316...51,067,908
Ensembl chr15:51,065,316...51,068,421
JBrowse link
G Nlrp12 NLR family, pyrin domain containing 12 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP12 mRNA CTD PMID:27935865 NCBI chr 1:64,506,750...64,543,908
Ensembl chr 1:64,506,735...64,534,912
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP3 mRNA CTD PMID:27935865 NCBI chr10:45,884,324...45,918,290
Ensembl chr10:45,893,018...45,918,254
JBrowse link
G Npy neuropeptide Y multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NPY mRNA CTD PMID:27935865 NCBI chr 4:79,557,856...79,565,059
Ensembl chr 4:79,557,854...79,565,097
JBrowse link
G Ntf3 neurotrophin 3 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of NTF3 mRNA] CTD PMID:29891994 NCBI chr 4:158,636,883...158,705,886
Ensembl chr 4:158,636,884...158,705,886
JBrowse link
G Olfml1 olfactomedin-like 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OLFML1 mRNA CTD PMID:27935865 NCBI chr 1:171,793,782...171,818,074
Ensembl chr 1:171,793,782...171,818,068
JBrowse link
G Opcml opioid binding protein/cell adhesion molecule-like multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OPCML mRNA CTD PMID:27935865 NCBI chr 8:28,842,202...29,967,300
Ensembl chr 8:29,453,643...29,962,825
JBrowse link
G Otop2 otopetrin 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of OTOP2 mRNA CTD PMID:27935865 NCBI chr10:103,874,383...103,883,953
Ensembl chr10:103,874,383...103,883,953
JBrowse link
G P2rx4 purinergic receptor P2X 4 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of P2RX4 mRNA] CTD PMID:29891994 NCBI chr12:39,308,022...39,325,673
Ensembl chr12:39,308,025...39,325,673
JBrowse link
G Pax1 paired box 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX1 mRNA CTD PMID:27935865 NCBI chr 3:141,577,124...141,589,849
Ensembl chr 3:141,577,504...141,589,849
JBrowse link
G Pax7 paired box 7 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX7 mRNA CTD PMID:27935865 NCBI chr 5:158,211,001...158,313,510
Ensembl chr 5:158,214,616...158,313,426
JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PCK1 mRNA CTD PMID:27935865 NCBI chr 3:171,213,936...171,219,885
Ensembl chr 3:171,213,936...171,219,871
JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PCK2 mRNA] CTD PMID:29891994 NCBI chr15:34,216,735...34,224,357
Ensembl chr15:34,216,833...34,224,193
JBrowse link
G Pde3a phosphodiesterase 3A multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PDE3A mRNA CTD PMID:27935865 NCBI chr 4:175,431,904...175,703,844
Ensembl chr 4:175,431,904...175,700,238
JBrowse link
G Perm1 PPARGC1 and ESRR induced regulator, muscle 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PERM1 mRNA CTD PMID:27935865 NCBI chr 5:173,640,780...173,646,073
Ensembl chr 5:173,640,780...173,646,073
JBrowse link
G Pgm5 phosphoglucomutase 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGM5 mRNA CTD PMID:27935865 NCBI chr 1:242,582,591...242,765,837
Ensembl chr 1:242,582,642...242,765,807
JBrowse link
G Pgr progesterone receptor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGR mRNA CTD PMID:27935865 NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
JBrowse link
G Phex phosphate regulating endopeptidase homolog, X-linked multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PHEX mRNA CTD PMID:27935865 NCBI chr  X:40,460,047...40,717,982
Ensembl chr  X:40,460,047...40,717,982
JBrowse link
G Pitx2 paired-like homeodomain 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PITX2 mRNA CTD PMID:27935865 NCBI chr 2:233,602,732...233,621,059
Ensembl chr 2:233,602,732...233,621,129
JBrowse link
G Pkhd1l1 PKHD1 like 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PKHD1L1 mRNA CTD PMID:27935865 NCBI chr 7:83,373,022...83,548,944
Ensembl chr 7:83,373,022...83,545,540
JBrowse link
G Pkn1 protein kinase N1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PKN1 mRNA] CTD PMID:29891994 NCBI chr19:24,803,524...24,832,305
Ensembl chr19:24,803,524...24,831,500
JBrowse link
G Plcb4 phospholipase C, beta 4 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PLCB4 mRNA] CTD PMID:29891994 NCBI chr 3:128,601,163...128,971,720
Ensembl chr 3:128,756,799...128,971,746
JBrowse link
G Plin1 perilipin 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PLIN1 mRNA CTD PMID:27935865 NCBI chr 1:141,458,907...141,470,927
Ensembl chr 1:141,458,181...141,471,010
JBrowse link
G Ppbp pro-platelet basic protein multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PPBP mRNA CTD PMID:27935865 NCBI chr14:18,852,433...18,853,237
Ensembl chr14:18,851,954...18,853,315
JBrowse link
G Prap1 proline-rich acidic protein 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PRAP1 mRNA CTD PMID:27935865 NCBI chr 1:212,558,257...212,562,053
Ensembl chr 1:212,558,257...212,562,051
JBrowse link
G Prdm6 PR/SET domain 6 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRDM6 mRNA CTD PMID:27935865 NCBI chr18:48,433,747...48,538,834
Ensembl chr18:48,434,652...48,538,023
JBrowse link
G Prok2 prokineticin 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PROK2 mRNA CTD PMID:27935865 NCBI chr 4:132,157,556...132,171,244
Ensembl chr 4:132,157,556...132,171,153
JBrowse link
G Prr32 proline rich 32 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRR32 mRNA CTD PMID:27935865 NCBI chr  X:131,617,765...131,619,762
Ensembl chr  X:131,617,798...131,619,728
JBrowse link
G Psors1c2 psoriasis susceptibility 1 candidate 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PSORS1C2 mRNA CTD PMID:27935865 NCBI chr20:3,727,817...3,728,805
Ensembl chr20:3,727,419...3,728,844
JBrowse link
G Ptgdr prostaglandin D2 receptor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGDR mRNA CTD PMID:27935865 NCBI chr15:19,195,606...19,196,508 JBrowse link
G Ptgfr prostaglandin F receptor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGFR mRNA CTD PMID:27935865 NCBI chr 2:257,005,813...257,039,036
Ensembl chr 2:257,005,829...257,038,105
JBrowse link
G Pwwp2b PWWP domain containing 2B multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PWWP2B mRNA] CTD PMID:29891994 NCBI chr 1:211,579,706...211,600,715
Ensembl chr 1:211,582,077...211,600,689
JBrowse link
G Pxmp2 peroxisomal membrane protein 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PXMP2 mRNA] CTD PMID:29891994 NCBI chr12:52,452,354...52,462,655
Ensembl chr12:52,452,273...52,462,659
JBrowse link
G Pycr1 pyrroline-5-carboxylate reductase 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PYCR1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PYCR1 mRNA] CTD PMID:27935865 PMID:29891994 NCBI chr10:109,817,300...109,822,218
Ensembl chr10:109,818,177...109,821,807
JBrowse link
G Rab17 RAB17, member RAS oncogene family multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB17 mRNA] CTD PMID:29891994 NCBI chr 9:98,118,907...98,131,883
Ensembl chr 9:98,118,908...98,131,883
JBrowse link
G Rab2b RAB2B, member RAS oncogene family multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB2B mRNA] CTD PMID:29891994 NCBI chr15:28,675,504...28,696,192
Ensembl chr15:28,677,055...28,696,122
JBrowse link
G Rap1gap Rap1 GTPase-activating protein multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAP1GAP mRNA] CTD PMID:29891994 NCBI chr 5:156,008,868...156,074,350
Ensembl chr 5:156,026,911...156,074,395
JBrowse link
G Rasd2 RASD family, member 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RASD2 mRNA CTD PMID:27935865 NCBI chr19:14,653,198...14,663,914
Ensembl chr19:14,653,198...14,663,914
JBrowse link
G Rcan2 regulator of calcineurin 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RCAN2 mRNA CTD PMID:27935865 NCBI chr 9:19,518,568...19,749,145
Ensembl chr 9:19,518,558...19,749,145
JBrowse link
G Rdm1 RAD52 motif containing 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RDM1 mRNA] CTD PMID:29891994 NCBI chr10:89,540,333...89,550,496
Ensembl chr10:89,539,556...89,550,500
JBrowse link
G Retn resistin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RETN mRNA CTD PMID:27935865 NCBI chr12:2,201,909...2,203,649
Ensembl chr12:2,201,891...2,204,249
JBrowse link
G Ripply1 ripply transcriptional repressor 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RIPPLY1 mRNA CTD PMID:27935865 NCBI chr  X:111,099,420...111,114,835
Ensembl chr  X:111,099,930...111,102,464
JBrowse link
G Robo4 roundabout guidance receptor 4 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ROBO4 mRNA CTD PMID:27935865 NCBI chr 8:39,082,693...39,093,344
Ensembl chr 8:39,083,327...39,093,277
JBrowse link
G Rras RAS related multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RRAS mRNA] CTD PMID:29891994 NCBI chr 1:101,012,822...101,016,720
Ensembl chr 1:101,012,822...101,016,720
JBrowse link
G Rtl3 retrotransposon Gag like 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RTL3 mRNA CTD PMID:27935865 NCBI chr  X:77,953,574...77,957,261
Ensembl chr  X:77,954,484...77,956,352
JBrowse link
G Runx1t1 RUNX1 partner transcriptional co-repressor 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RUNX1T1 mRNA CTD PMID:27935865 NCBI chr 5:27,284,921...27,440,802
Ensembl chr 5:27,312,928...27,442,841
JBrowse link
G S100a8 S100 calcium binding protein A8 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A8 mRNA CTD PMID:27935865 NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
JBrowse link
G S100a9 S100 calcium binding protein A9 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A9 mRNA CTD PMID:27935865 NCBI chr 2:190,097,436...190,100,209
Ensembl chr 2:190,097,554...190,100,276
JBrowse link
G Samsn1 SAM domain, SH3 domain and nuclear localization signals, 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SAMSN1 mRNA CTD PMID:27935865 NCBI chr11:14,252,088...14,405,825
Ensembl chr11:14,253,848...14,304,725
JBrowse link
G Sbk2 SH3 domain binding kinase family, member 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SBK2 mRNA CTD PMID:27935865 NCBI chr 1:72,425,728...72,433,494
Ensembl chr 1:72,425,707...72,433,488
JBrowse link
G Scg3 secretogranin III multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCG3 mRNA CTD PMID:27935865 NCBI chr 8:82,582,352...82,641,536
Ensembl chr 8:82,582,352...82,641,536
JBrowse link
G Sell selectin L multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELL mRNA CTD PMID:27935865 NCBI chr13:82,369,820...82,387,774
Ensembl chr13:82,369,493...82,387,631
JBrowse link
G Selp selectin P multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELP mRNA CTD PMID:27935865 NCBI chr13:82,428,914...82,464,629
Ensembl chr13:82,429,063...82,464,628
JBrowse link
G Sfrp1 secreted frizzled-related protein 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SFRP1 mRNA] CTD PMID:29891994 NCBI chr16:73,372,007...73,410,777
Ensembl chr16:73,372,007...73,410,777
JBrowse link
G Sh2d5 SH2 domain containing 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SH2D5 mRNA CTD PMID:27935865 NCBI chr 5:156,615,889...156,624,962
Ensembl chr 5:156,613,741...156,626,529
JBrowse link
G Shisa8 shisa family member 8 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHISA8 mRNA CTD PMID:27935865 NCBI chr 7:123,440,163...123,445,613
Ensembl chr 7:123,440,163...123,445,613
JBrowse link
G Shox2 short stature homeobox 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHOX2 mRNA CTD PMID:27935865 NCBI chr 2:164,118,175...164,126,783
Ensembl chr 2:164,118,191...164,126,783
JBrowse link
G Slc12a8 solute carrier family 12, member 8 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC12A8 mRNA CTD PMID:27935865 NCBI chr11:70,344,771...70,499,202
Ensembl chr11:70,344,797...70,499,200
JBrowse link
G Slc1a3 solute carrier family 1 member 3 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A3 mRNA] CTD PMID:29891994 NCBI chr 2:57,860,881...57,935,363
Ensembl chr 2:57,860,834...57,935,363
JBrowse link
G Slc1a5 solute carrier family 1 member 5 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A5 mRNA] CTD PMID:29891994 NCBI chr 1:78,710,686...78,724,789
Ensembl chr 1:78,710,539...78,724,794
JBrowse link
G Slc25a34 solute carrier family 25, member 34 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC25A34 mRNA CTD PMID:27935865 NCBI chr 5:160,175,206...160,179,978
Ensembl chr 5:160,176,124...160,179,978
JBrowse link
G Slc26a7 solute carrier family 26 member 7 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC26A7 mRNA CTD PMID:27935865 NCBI chr 5:27,986,656...28,131,294
Ensembl chr 5:27,986,663...28,177,340
JBrowse link
G Slc2a13 solute carrier family 2 member 13 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC2A13 mRNA CTD PMID:27935865 NCBI chr 7:132,430,852...132,757,558
Ensembl chr 7:132,430,853...132,757,558
JBrowse link
G Slc2a3 solute carrier family 2 member 3 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC2A3 mRNA CTD PMID:27935865 NCBI chr 4:155,549,991...155,626,018
Ensembl chr 4:155,408,233...155,631,856
JBrowse link
G Slc38a11 solute carrier family 38, member 11 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC38A11 mRNA CTD PMID:27935865 NCBI chr 3:51,370,388...51,416,873
Ensembl chr 3:51,371,923...51,416,646
JBrowse link
G Slc38a5 solute carrier family 38, member 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC38A5 mRNA CTD PMID:27935865 NCBI chr  X:14,963,919...14,972,675
Ensembl chr  X:14,963,921...14,972,675
JBrowse link
G Slc5a7 solute carrier family 5 member 7 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC5A7 mRNA CTD PMID:27935865 NCBI chr 9:5,294,377...5,330,822
Ensembl chr 9:5,294,381...5,330,815
JBrowse link
G Slc6a12 solute carrier family 6 member 12 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC6A12 mRNA CTD PMID:27935865 NCBI chr 4:153,921,199...153,941,333
Ensembl chr 4:153,921,115...153,941,391
JBrowse link
G Sln sarcolipin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLN mRNA CTD PMID:27935865 NCBI chr 8:58,431,407...58,435,654
Ensembl chr 8:58,431,407...58,435,654
JBrowse link
G Snph syntaphilin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SNPH mRNA CTD PMID:27935865 NCBI chr 3:147,102,394...147,143,576
Ensembl chr 3:147,102,394...147,143,576
JBrowse link
G Sorcs1 sortilin-related VPS10 domain containing receptor 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SORCS1 mRNA CTD PMID:27935865 NCBI chr 1:269,965,824...270,473,097
Ensembl chr 1:269,973,351...270,472,866
JBrowse link
G Sox10 SRY-box transcription factor 10 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SOX10 mRNA CTD PMID:27935865 NCBI chr 7:120,393,238...120,403,523
Ensembl chr 7:120,393,254...120,403,523
JBrowse link
G Sox9 SRY-box transcription factor 9 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SOX9 mRNA] CTD PMID:29891994 NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
JBrowse link
G Spats2l spermatogenesis associated, serine-rich 2-like multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SPATS2L mRNA] CTD PMID:29891994 NCBI chr 9:64,643,223...64,843,963
Ensembl chr 9:64,643,281...64,843,960
JBrowse link
G Spon1 spondin 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SPON1 mRNA CTD PMID:27935865 NCBI chr 1:178,568,777...178,935,715
Ensembl chr 1:178,636,544...178,935,051
JBrowse link
G Sprr1b small proline-rich protein 1B multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR1B mRNA CTD PMID:27935865 NCBI chr 2:192,622,972...192,624,848
Ensembl chr 2:192,623,244...192,623,681
JBrowse link
G Sprr2d small proline-rich protein 2D multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2D mRNA CTD PMID:27935865 NCBI chr 2:192,480,676...192,481,990
Ensembl chr 2:192,481,028...192,481,273
JBrowse link
G Sprr2f small proline rich protein 2F multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2F mRNA CTD PMID:27935865 NCBI chr 2:192,604,978...192,605,208 JBrowse link
G Srgn serglycin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SRGN mRNA CTD PMID:27935865 NCBI chr20:32,120,317...32,158,071
Ensembl chr20:32,120,320...32,139,789
JBrowse link
G Srpx sushi-repeat-containing protein, X-linked multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SRPX mRNA CTD PMID:27935865 NCBI chr  X:14,146,618...14,220,756
Ensembl chr  X:14,150,038...14,220,662
JBrowse link
G St6galnac2 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ST6GALNAC2 mRNA] CTD PMID:29891994 NCBI chr10:105,650,866...105,668,579
Ensembl chr10:105,650,862...105,668,593
JBrowse link
G Stard10 StAR-related lipid transfer domain containing 10 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STARD10 mRNA] CTD PMID:29891994 NCBI chr 1:166,428,780...166,458,413
Ensembl chr 1:166,428,761...166,457,509
JBrowse link
G Stc2 stanniocalcin 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STC2 mRNA] CTD PMID:29891994 NCBI chr10:16,542,909...16,552,675
Ensembl chr10:16,542,882...16,553,295
JBrowse link
G Stxbp5l syntaxin binding protein 5-like multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of STXBP5L mRNA CTD PMID:27935865 NCBI chr11:66,246,624...66,566,331
Ensembl chr11:66,316,606...66,566,331
JBrowse link
G Susd5 sushi domain containing 5 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SUSD5 mRNA CTD PMID:27935865 NCBI chr 8:122,331,489...122,370,684
Ensembl chr 8:122,331,583...122,368,368
JBrowse link
G Svopl SVOP like multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SVOPL mRNA CTD PMID:27935865 NCBI chr 4:65,667,164...65,733,222
Ensembl chr 4:65,668,338...65,733,001
JBrowse link
G Tagln transgelin multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TAGLN mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TAGLN mRNA] CTD PMID:27935865 PMID:29891994 NCBI chr 8:50,222,895...50,228,369
Ensembl chr 8:50,222,896...50,231,357
JBrowse link
G Tarm1 T cell-interacting, activating receptor on myeloid cells 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TARM1 mRNA CTD PMID:27935865 NCBI chr 1:64,241,742...64,256,646
Ensembl chr 1:64,241,865...64,254,564
JBrowse link
G Tbc1d16 TBC1 domain family, member 16 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TBC1D16 mRNA] CTD PMID:29891994 NCBI chr10:108,257,492...108,321,899
Ensembl chr10:108,258,240...108,321,644
JBrowse link
G Tbx15 T-box transcription factor 15 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBX15 mRNA CTD PMID:27935865 NCBI chr 2:201,289,042...201,390,752
Ensembl chr 2:201,289,357...201,390,745
JBrowse link
G Tbxa2r thromboxane A2 receptor multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBXA2R mRNA CTD PMID:27935865 NCBI chr 7:11,253,153...11,259,233
Ensembl chr 7:11,253,180...11,257,977
JBrowse link
G Tdo2 tryptophan 2,3-dioxygenase multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TDO2 mRNA CTD PMID:27935865 NCBI chr 2:180,897,059...180,914,919
Ensembl chr 2:180,897,011...180,914,940
JBrowse link
G Tff2 trefoil factor 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TFF2 mRNA CTD PMID:27935865 NCBI chr20:9,872,669...9,876,008
Ensembl chr20:9,872,680...9,876,008
JBrowse link
G Tgm2 transglutaminase 2 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TGM2 mRNA] CTD PMID:29891994 NCBI chr 3:154,597,165...154,627,257
Ensembl chr 3:154,597,168...154,627,257
JBrowse link
G Thrsp thyroid hormone responsive multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of THRSP mRNA CTD PMID:27935865 NCBI chr 1:162,381,251...162,385,575
Ensembl chr 1:162,381,253...162,385,575
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TIMP1 mRNA CTD PMID:27935865 NCBI chr  X:1,364,771...1,369,451
Ensembl chr  X:1,364,786...1,369,384
JBrowse link
G Tmem132c transmembrane protein 132C multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM132C mRNA CTD PMID:27935865 NCBI chr12:32,806,372...33,130,746
Ensembl chr12:32,808,022...33,016,885
JBrowse link
G Tmem182 transmembrane protein 182 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM182 mRNA CTD PMID:27935865 NCBI chr 9:47,536,824...47,588,677
Ensembl chr 9:47,536,824...47,588,677
JBrowse link
G Tmem252 transmembrane protein 252 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TMEM252 mRNA CTD PMID:27935865 NCBI chr 1:242,572,558...242,577,817
Ensembl chr 1:242,572,533...242,577,817
JBrowse link
G Tmem255a transmembrane protein 255A multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM255A mRNA CTD PMID:27935865 NCBI chr  X:124,400,686...124,465,156
Ensembl chr  X:124,328,735...124,465,110
JBrowse link
G Tmem30b transmembrane protein 30B multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TMEM30B mRNA] CTD PMID:29891994 NCBI chr 6:96,439,607...96,442,682
Ensembl chr 6:96,439,607...96,442,682
JBrowse link
G Tnc tenascin C multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNC mRNA] CTD PMID:29891994 NCBI chr 5:79,789,686...79,874,555
Ensembl chr 5:79,789,671...79,874,671
JBrowse link
G Tnfrsf14 TNF receptor superfamily member 14 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNFRSF14 mRNA] CTD PMID:29891994 NCBI chr 5:172,328,259...172,337,221
Ensembl chr 5:172,328,262...172,335,892
JBrowse link
G Tnfsf14 TNF superfamily member 14 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF14 mRNA CTD PMID:27935865 NCBI chr 9:9,761,363...9,765,461
Ensembl chr 9:9,761,536...9,765,186
JBrowse link
G Tnfsf9 TNF superfamily member 9 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF9 mRNA CTD PMID:27935865 NCBI chr 9:9,909,942...9,912,276
Ensembl chr 9:9,909,948...9,912,276
JBrowse link
G Tnni2 troponin I2, fast skeletal type multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNNI2 mRNA] CTD PMID:29891994 NCBI chr 1:215,609,110...215,611,652
Ensembl chr 1:215,609,036...215,611,658
JBrowse link
G Tnnt1 troponin T1, slow skeletal type multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TNNT1 mRNA CTD PMID:27935865 NCBI chr 1:72,889,270...72,899,629
Ensembl chr 1:72,889,270...72,899,659
JBrowse link
G Tpd52l1 TPD52 like 1 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TPD52L1 mRNA] CTD PMID:29891994 NCBI chr 1:28,454,949...28,578,736
Ensembl chr 1:28,454,966...28,576,553
JBrowse link
G Trarg1 trafficking regulator of GLUT4 (SLC2A4) 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRARG1 mRNA CTD PMID:27935865 NCBI chr10:63,471,330...63,491,713
Ensembl chr10:63,471,331...63,491,713
JBrowse link
G Trem1 triggering receptor expressed on myeloid cells 1 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TREM1 mRNA CTD PMID:27935865 NCBI chr 9:14,727,887...14,743,371
Ensembl chr 9:14,727,976...14,809,447
JBrowse link
G Tril TLR4 interactor with leucine-rich repeats multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRIL mRNA CTD PMID:27935865 NCBI chr 4:83,967,695...83,972,540
Ensembl chr 4:83,967,696...83,972,540
JBrowse link
G Tst thiosulfate sulfurtransferase multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TST mRNA] CTD PMID:29891994 NCBI chr 7:119,616,323...119,623,072
Ensembl chr 7:119,616,324...119,623,072
JBrowse link
G Tubb3 tubulin, beta 3 class III multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TUBB3 mRNA CTD PMID:27935865 NCBI chr19:56,220,759...56,229,813
Ensembl chr19:56,220,755...56,229,813
JBrowse link
G Twist2 twist family bHLH transcription factor 2 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TWIST2 mRNA CTD PMID:27935865 NCBI chr 9:98,924,134...98,968,510
Ensembl chr 9:98,924,134...98,968,510
JBrowse link
G Txlnb taxilin beta multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TXLNB mRNA CTD PMID:27935865 NCBI chr 1:12,915,781...12,961,680
Ensembl chr 1:12,915,734...12,961,670
JBrowse link
G Upk3a uroplakin 3A multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of UPK3A mRNA CTD PMID:27935865 NCBI chr 7:125,920,357...125,925,430
Ensembl chr 7:125,920,357...125,925,430
JBrowse link
G Wnt2b Wnt family member 2B multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of WNT2B mRNA CTD PMID:27935865 NCBI chr 2:207,433,771...207,457,094
Ensembl chr 2:207,440,886...207,455,258
JBrowse link
G Zfp366 zinc finger protein 366 multiple interactions ISO [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ZFP366 mRNA CTD PMID:27935865 NCBI chr 2:29,410,169...29,498,661
Ensembl chr 2:29,410,579...29,498,664
JBrowse link
G Zfp524 zinc finger protein 524 multiple interactions ISO XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ZNF524 mRNA] CTD PMID:29891994 NCBI chr 1:72,376,381...72,379,884
Ensembl chr 1:72,376,386...72,377,434
JBrowse link
XL765 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aldh5a1 aldehyde dehydrogenase 5 family, member A1 increases response to substance ISO ALDH5A1 gene mutant form results in increased susceptibility to XL765 CTD PMID:29031482 NCBI chr17:42,133,076...42,159,413
Ensembl chr17:42,133,076...42,159,413
JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases activity ISO XL765 results in decreased activity of MTOR protein CTD PMID:29031482 NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19810
    chemical entity 19810
      molecular entity 19808
        mancude ring 8123
          organic mancude parent 8123
            mancude organic heterocyclic parent 8123
              mancude organic heterobicyclic parent 5202
                quinoxaline 376
                  quinoxaline derivative 376
                    (5Z)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione 0
                    1,4-dihydroxyquinoxaline-2,3-dione 0
                    1-(2,3-dimethyl-6-quinoxalinyl)-3-(3-hydroxypropyl)thiourea 0
                    1-(3-methyl-1-piperidinyl)-2-(2-quinoxalinylthio)ethanone 0
                    1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea 0
                    1-(4-methoxyphenyl)-3-(6-quinoxalinyl)thiourea 0
                    1-(4-methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone 0
                    1-(thiophen-2-ylmethyl)-3-thiophen-2-ylsulfonyl-2-pyrrolo[3,2-b]quinoxalinamine 0
                    1-[(3,4-dimethoxyphenyl)methylideneamino]-3-thiophen-2-ylsulfonyl-2-pyrrolo[3,2-b]quinoxalinamine 0
                    1-[2,3-bis(2-pyridinyl)-6-quinoxalinyl]-3-propylthiourea 0
                    1-[2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl]-3-phenylurea 0
                    1-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester 0
                    1-[4-[2-(2,5-dimethyl-1-pyrrolyl)ethyl]-1-piperazinyl]-2-[[3-(4-morpholinyl)-2-quinoxalinyl]thio]ethanone 0
                    1-butyl-3-thiophen-2-ylsulfonyl-2H-imidazo[4,5-b]quinoxaline 0
                    1-phenylmethoxy-4-prop-2-enoxyquinoxaline-2,3-dione 0
                    2,3-bis(2-pyridinyl)quinoxaline 0
                    2,3-dimethyl-6-quinoxalinecarboxylic acid (2-bromophenyl)methyl ester 0
                    2,3-dimethylquinoxaline 0
                    2,3-diphenyl-6-quinoxalinecarboxylic acid 0
                    2-(2-quinoxalinylthio)propanoic acid 0
                    2-(3-methylphenyl)sulfonyl-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetonitrile 0
                    2-(3-oxo-4H-quinoxalin-2-yl)propanoic acid ethyl ester 0
                    2-(4,5-dihydro-1H-imidazol-2-yl)quinoxaline 0
                    2-(4-chlorophenyl)sulfonylquinoxaline 0
                    2-(4-methoxyphenyl)sulfonylquinoxaline 0
                    2-[(3-chlorophenyl)methoxy]-3-methylquinoxaline 0
                    2-[7-chloro-2,3-dioxo-4-(phenylmethyl)-1-quinoxalinyl]-N-(3-fluorophenyl)acetamide 0
                    2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-N-(2-phenylethyl)acetamide 0
                    2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-N-phenylacetamide 0
                    2-[[[2-amino-1-(3-methoxypropyl)-3-pyrrolo[3,2-b]quinoxalinyl]-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester 0
                    2-\{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy\}propanoic acid + 4
                    2-amino-1-(1,3-benzodioxol-5-yl)-N-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxamide 0
                    2-amino-1-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester 0
                    2-amino-1-[2-(4-morpholinyl)ethyl]-N-prop-2-enyl-3-pyrrolo[3,2-b]quinoxalinecarboxamide 0
                    2-amino-1-cyclohexyl-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester 0
                    2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid cyclohexyl ester 0
                    2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid hexyl ester 0
                    2-cyano-N-(2-furanylmethyl)-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetamide 0
                    2-cyano-N-(3-methoxypropyl)-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetamide 0
                    2-cyano-N-(phenylmethyl)-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetamide 0
                    2-methylquinoxaline 0
                    2-methylquinoxaline-6-carboxylic acid 0
                    2H-pyrazolo[4,3-b]quinoxalin-3-amine 0
                    3-(2-methoxyphenyl)-2-phenylbenzo[g]quinoxaline 0
                    3-(2-oxo-2-thiophen-2-ylethyl)-1H-quinoxalin-2-one 0
                    3-(4-butyl-3-oxo-2-quinoxalinyl)propanoic acid [2-(3-chloro-4-fluoroanilino)-2-oxoethyl] ester 0
                    3-(4-methylphenyl)sulfonyl-1-(3-oxolanylmethyl)-2-pyrrolo[3,2-b]quinoxalinamine 0
                    3-(benzenesulfonyl)-1-cyclopropyl-2-pyrrolo[3,2-b]quinoxalinamine 0
                    3-(phenylmethyl)-1H-quinoxalin-2-one 0
                    3-[3-oxo-4-(2-phenylethyl)-2-quinoxalinyl]propanoic acid 0
                    3-[[3-[(4-acetamidophenyl)sulfonylamino]-1,4-dihydroquinoxalin-2-yl]imino]-6-oxo-1-cyclohexa-1,4-dienecarboxylic acid 0
                    3-nitro-N-(6-quinoxalinylmethylideneamino)benzamide 0
                    3-phenyl-1H-quinoxalin-2-one 0
                    3-pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester 0
                    4-(2-quinoxalinylamino)benzoic acid ethyl ester 0
                    4-(4-tetrazolo[1,5-a]quinoxalinyl)morpholine 0
                    4-[2-(9-methyl-6-indolo[3,2-b]quinoxalinyl)ethyl]morpholine 0
                    4-[3-(2-phenoxyethoxy)-2-quinoxalinyl]morpholine 0
                    4-[[3-[(4-chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                    4-[[[2,3-bis(2-pyridinyl)-6-quinoxalinyl]amino]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester 0
                    4-bromo-N-(6-quinoxalinylmethylideneamino)benzamide 0
                    4-chloro-N-[3-[(3,5-dimethyl-4-isoxazolyl)methylthio]-2-quinoxalinyl]benzenesulfonamide 0
                    4-chlorobenzoic acid 2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl ester 0
                    5-(6-quinoxalinylmethylidene)thiazolidine-2,4-dione 0
                    5-[[1-oxo-3-(3-oxo-4H-quinoxalin-2-yl)propoxy]methyl]-2-furancarboxylic acid ethyl ester 0
                    5-bromo-N-[3-(3,5-dimethyl-1-pyridin-1-iumyl)-2-quinoxalinyl]-2-thiophenesulfonamide 0
                    5-methylquinoxaline 0
                    6,11-dihydroquinoxalino[2,3-b]quinoxaline 0
                    6,7-dichloro-1,4-dihydroquinoxaline-2,3-dione 0
                    6,7-dimethoxy-2-phenylquinoxaline 5
                    6,7-dimethoxy-4-[(3R)-3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]quinazoline 0
                    6,7-dimethyl-2-phenylquinoxaline 0
                    6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione 0
                    6-Cyano-7-nitroquinoxaline-2,3-dione 14
                    6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline 0
                    6-[[(6-methyl-9-indolo[3,2-b]quinoxalinyl)amino]methylidene]-1-cyclohexa-2,4-dienone 0
                    6-quinoxalinecarboxylic acid phenyl ester 0
                    8-methyl-N-[(4-methylphenyl)methyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine 0
                    9-bromo-6-[(3,4-dimethoxyphenyl)methyl]indolo[3,2-b]quinoxaline 0
                    9-chloro-6-methylindolo[3,2-b]quinoxaline 0
                    9-methoxy-6-[(4-methoxyphenyl)methyl]indolo[3,2-b]quinoxaline 0
                    CGP 78608 0
                    LSM-2128 0
                    LSM-23818 0
                    LSM-25764 0
                    LSM-27020 0
                    LSM-31289 0
                    LSM-32614 0
                    N',2-dimethyl-N'-[3-(trifluoromethyl)-2-quinoxalinyl]benzohydrazide 0
                    N'-(1,8-dimethyl-4-imidazo[1,2-a]quinoxalinyl)ethane-1,2-diamine 0
                    N(2)-[3-(3-oxo-3,4-dihydroquinoxalin-2-yl)propanoyl]-L-serinamide 0
                    N-(1,3-benzodioxol-5-yl)-2,3-diethyl-6-quinoxalinecarboxamide 0
                    N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine 0
                    N-(3-anilino-2-quinoxalinyl)-4-ethoxybenzenesulfonamide 0
                    N-(3-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine 0
                    N-(4-methoxyphenyl)-3-methyl-2-quinoxalinamine 0
                    N-(4-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine 0
                    N-(4-tert-butyl-2-thiazolyl)-6-quinoxalinecarboxamide 0
                    N-[(1-hydroxy-4-oxido-2-quinoxalin-4-iumylidene)methylimino]carbamic acid methyl ester 0
                    N-[(2-methoxyphenyl)methyl]-6H-indolo[2,3-b]quinoxaline-2-carboxamide 0
                    N-[1,4-dimethyl-2,3-dioxo-7-(1-piperidinyl)-6-quinoxalinyl]-4-ethylbenzenesulfonamide 0
                    N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[[3-(1-pyrrolidinyl)-2-quinoxalinyl]thio]acetamide 0
                    N-[2-(4-methoxyphenyl)ethyl]-2-quinoxalinecarboxamide 0
                    N-[3-(2-furanylmethylamino)-2-quinoxalinyl]-3-methylbenzenesulfonamide 0
                    N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine 0
                    N-[3-(benzenesulfonyl)-1-cyclohexyl-2-pyrrolo[3,2-b]quinoxalinyl]benzenesulfonamide 0
                    N-[3-[2-(1-cyclohexenyl)ethylamino]-2-quinoxalinyl]benzenesulfonamide 0
                    N-[3-[3-(1-piperidinylsulfonyl)anilino]-2-quinoxalinyl]benzenesulfonamide 0
                    N-[4-[[3-(4-sulfamoylanilino)-2-quinoxalinyl]sulfamoyl]phenyl]acetamide 0
                    N-[4-[cyano-[3-(3-hydroxypropylamino)-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide 0
                    N-[4-[cyano-[3-[2-(4-morpholinyl)ethylamino]-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide 0
                    N-cycloheptyl-3-(2-quinoxalinyl)-2-propenamide 0
                    XL147 311
                    XL765 2
                    brimonidine + 8
                    caroverine 0
                    cyclazosin + 1
                    ethyl 2-\{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy\}propanoate + 4
                    grazoprevir + 0
                    hydroxyquinoxaline + 12
                    propaquizafop 0
                    quinoxaline pesticide + 29
                    quinoxaline-2-carboxylic acid 0
                    rhosin 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19810
    subatomic particle 19808
      composite particle 19808
        hadron 19808
          baryon 19808
            nucleon 19808
              atomic nucleus 19808
                atom 19808
                  main group element atom 19696
                    p-block element atom 19696
                      carbon group element atom 19599
                        carbon atom 19588
                          organic molecular entity 19588
                            organic molecule 19514
                              organic cyclic compound 19311
                                organic heterocyclic compound 18425
                                  organic heteropolycyclic compound 17838
                                    organic heterobicyclic compound 16763
                                      mancude organic heterobicyclic parent 5202
                                        naphthyridine 770
                                          quinoxaline 376
                                            quinoxaline derivative 376
                                              (5Z)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione 0
                                              1,4-dihydroxyquinoxaline-2,3-dione 0
                                              1-(2,3-dimethyl-6-quinoxalinyl)-3-(3-hydroxypropyl)thiourea 0
                                              1-(3-methyl-1-piperidinyl)-2-(2-quinoxalinylthio)ethanone 0
                                              1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea 0
                                              1-(4-methoxyphenyl)-3-(6-quinoxalinyl)thiourea 0
                                              1-(4-methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone 0
                                              1-(thiophen-2-ylmethyl)-3-thiophen-2-ylsulfonyl-2-pyrrolo[3,2-b]quinoxalinamine 0
                                              1-[(3,4-dimethoxyphenyl)methylideneamino]-3-thiophen-2-ylsulfonyl-2-pyrrolo[3,2-b]quinoxalinamine 0
                                              1-[2,3-bis(2-pyridinyl)-6-quinoxalinyl]-3-propylthiourea 0
                                              1-[2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl]-3-phenylurea 0
                                              1-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester 0
                                              1-[4-[2-(2,5-dimethyl-1-pyrrolyl)ethyl]-1-piperazinyl]-2-[[3-(4-morpholinyl)-2-quinoxalinyl]thio]ethanone 0
                                              1-butyl-3-thiophen-2-ylsulfonyl-2H-imidazo[4,5-b]quinoxaline 0
                                              1-phenylmethoxy-4-prop-2-enoxyquinoxaline-2,3-dione 0
                                              2,3-bis(2-pyridinyl)quinoxaline 0
                                              2,3-dimethyl-6-quinoxalinecarboxylic acid (2-bromophenyl)methyl ester 0
                                              2,3-dimethylquinoxaline 0
                                              2,3-diphenyl-6-quinoxalinecarboxylic acid 0
                                              2-(2-quinoxalinylthio)propanoic acid 0
                                              2-(3-methylphenyl)sulfonyl-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetonitrile 0
                                              2-(3-oxo-4H-quinoxalin-2-yl)propanoic acid ethyl ester 0
                                              2-(4,5-dihydro-1H-imidazol-2-yl)quinoxaline 0
                                              2-(4-chlorophenyl)sulfonylquinoxaline 0
                                              2-(4-methoxyphenyl)sulfonylquinoxaline 0
                                              2-[(3-chlorophenyl)methoxy]-3-methylquinoxaline 0
                                              2-[7-chloro-2,3-dioxo-4-(phenylmethyl)-1-quinoxalinyl]-N-(3-fluorophenyl)acetamide 0
                                              2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-N-(2-phenylethyl)acetamide 0
                                              2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-N-phenylacetamide 0
                                              2-[[[2-amino-1-(3-methoxypropyl)-3-pyrrolo[3,2-b]quinoxalinyl]-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester 0
                                              2-\{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy\}propanoic acid + 4
                                              2-amino-1-(1,3-benzodioxol-5-yl)-N-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxamide 0
                                              2-amino-1-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester 0
                                              2-amino-1-[2-(4-morpholinyl)ethyl]-N-prop-2-enyl-3-pyrrolo[3,2-b]quinoxalinecarboxamide 0
                                              2-amino-1-cyclohexyl-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester 0
                                              2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid cyclohexyl ester 0
                                              2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid hexyl ester 0
                                              2-cyano-N-(2-furanylmethyl)-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetamide 0
                                              2-cyano-N-(3-methoxypropyl)-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetamide 0
                                              2-cyano-N-(phenylmethyl)-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetamide 0
                                              2-methylquinoxaline 0
                                              2-methylquinoxaline-6-carboxylic acid 0
                                              2H-pyrazolo[4,3-b]quinoxalin-3-amine 0
                                              3-(2-methoxyphenyl)-2-phenylbenzo[g]quinoxaline 0
                                              3-(2-oxo-2-thiophen-2-ylethyl)-1H-quinoxalin-2-one 0
                                              3-(4-butyl-3-oxo-2-quinoxalinyl)propanoic acid [2-(3-chloro-4-fluoroanilino)-2-oxoethyl] ester 0
                                              3-(4-methylphenyl)sulfonyl-1-(3-oxolanylmethyl)-2-pyrrolo[3,2-b]quinoxalinamine 0
                                              3-(benzenesulfonyl)-1-cyclopropyl-2-pyrrolo[3,2-b]quinoxalinamine 0
                                              3-(phenylmethyl)-1H-quinoxalin-2-one 0
                                              3-[3-oxo-4-(2-phenylethyl)-2-quinoxalinyl]propanoic acid 0
                                              3-[[3-[(4-acetamidophenyl)sulfonylamino]-1,4-dihydroquinoxalin-2-yl]imino]-6-oxo-1-cyclohexa-1,4-dienecarboxylic acid 0
                                              3-nitro-N-(6-quinoxalinylmethylideneamino)benzamide 0
                                              3-phenyl-1H-quinoxalin-2-one 0
                                              3-pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester 0
                                              4-(2-quinoxalinylamino)benzoic acid ethyl ester 0
                                              4-(4-tetrazolo[1,5-a]quinoxalinyl)morpholine 0
                                              4-[2-(9-methyl-6-indolo[3,2-b]quinoxalinyl)ethyl]morpholine 0
                                              4-[3-(2-phenoxyethoxy)-2-quinoxalinyl]morpholine 0
                                              4-[[3-[(4-chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                                              4-[[[2,3-bis(2-pyridinyl)-6-quinoxalinyl]amino]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester 0
                                              4-bromo-N-(6-quinoxalinylmethylideneamino)benzamide 0
                                              4-chloro-N-[3-[(3,5-dimethyl-4-isoxazolyl)methylthio]-2-quinoxalinyl]benzenesulfonamide 0
                                              4-chlorobenzoic acid 2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl ester 0
                                              5-(6-quinoxalinylmethylidene)thiazolidine-2,4-dione 0
                                              5-[[1-oxo-3-(3-oxo-4H-quinoxalin-2-yl)propoxy]methyl]-2-furancarboxylic acid ethyl ester 0
                                              5-bromo-N-[3-(3,5-dimethyl-1-pyridin-1-iumyl)-2-quinoxalinyl]-2-thiophenesulfonamide 0
                                              5-methylquinoxaline 0
                                              6,11-dihydroquinoxalino[2,3-b]quinoxaline 0
                                              6,7-dichloro-1,4-dihydroquinoxaline-2,3-dione 0
                                              6,7-dimethoxy-2-phenylquinoxaline 5
                                              6,7-dimethoxy-4-[(3R)-3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]quinazoline 0
                                              6,7-dimethyl-2-phenylquinoxaline 0
                                              6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione 0
                                              6-Cyano-7-nitroquinoxaline-2,3-dione 14
                                              6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline 0
                                              6-[[(6-methyl-9-indolo[3,2-b]quinoxalinyl)amino]methylidene]-1-cyclohexa-2,4-dienone 0
                                              6-quinoxalinecarboxylic acid phenyl ester 0
                                              8-methyl-N-[(4-methylphenyl)methyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine 0
                                              9-bromo-6-[(3,4-dimethoxyphenyl)methyl]indolo[3,2-b]quinoxaline 0
                                              9-chloro-6-methylindolo[3,2-b]quinoxaline 0
                                              9-methoxy-6-[(4-methoxyphenyl)methyl]indolo[3,2-b]quinoxaline 0
                                              CGP 78608 0
                                              LSM-2128 0
                                              LSM-23818 0
                                              LSM-25764 0
                                              LSM-27020 0
                                              LSM-31289 0
                                              LSM-32614 0
                                              N',2-dimethyl-N'-[3-(trifluoromethyl)-2-quinoxalinyl]benzohydrazide 0
                                              N'-(1,8-dimethyl-4-imidazo[1,2-a]quinoxalinyl)ethane-1,2-diamine 0
                                              N(2)-[3-(3-oxo-3,4-dihydroquinoxalin-2-yl)propanoyl]-L-serinamide 0
                                              N-(1,3-benzodioxol-5-yl)-2,3-diethyl-6-quinoxalinecarboxamide 0
                                              N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine 0
                                              N-(3-anilino-2-quinoxalinyl)-4-ethoxybenzenesulfonamide 0
                                              N-(3-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine 0
                                              N-(4-methoxyphenyl)-3-methyl-2-quinoxalinamine 0
                                              N-(4-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine 0
                                              N-(4-tert-butyl-2-thiazolyl)-6-quinoxalinecarboxamide 0
                                              N-[(1-hydroxy-4-oxido-2-quinoxalin-4-iumylidene)methylimino]carbamic acid methyl ester 0
                                              N-[(2-methoxyphenyl)methyl]-6H-indolo[2,3-b]quinoxaline-2-carboxamide 0
                                              N-[1,4-dimethyl-2,3-dioxo-7-(1-piperidinyl)-6-quinoxalinyl]-4-ethylbenzenesulfonamide 0
                                              N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[[3-(1-pyrrolidinyl)-2-quinoxalinyl]thio]acetamide 0
                                              N-[2-(4-methoxyphenyl)ethyl]-2-quinoxalinecarboxamide 0
                                              N-[3-(2-furanylmethylamino)-2-quinoxalinyl]-3-methylbenzenesulfonamide 0
                                              N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine 0
                                              N-[3-(benzenesulfonyl)-1-cyclohexyl-2-pyrrolo[3,2-b]quinoxalinyl]benzenesulfonamide 0
                                              N-[3-[2-(1-cyclohexenyl)ethylamino]-2-quinoxalinyl]benzenesulfonamide 0
                                              N-[3-[3-(1-piperidinylsulfonyl)anilino]-2-quinoxalinyl]benzenesulfonamide 0
                                              N-[4-[[3-(4-sulfamoylanilino)-2-quinoxalinyl]sulfamoyl]phenyl]acetamide 0
                                              N-[4-[cyano-[3-(3-hydroxypropylamino)-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide 0
                                              N-[4-[cyano-[3-[2-(4-morpholinyl)ethylamino]-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide 0
                                              N-cycloheptyl-3-(2-quinoxalinyl)-2-propenamide 0
                                              XL147 311
                                              XL765 2
                                              brimonidine + 8
                                              caroverine 0
                                              cyclazosin + 1
                                              ethyl 2-\{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy\}propanoate + 4
                                              grazoprevir + 0
                                              hydroxyquinoxaline + 12
                                              propaquizafop 0
                                              quinoxaline pesticide + 29
                                              quinoxaline-2-carboxylic acid 0
                                              rhosin 0
paths to the root